Shelton Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Sell |
9,493
-179
| -2% | -$4.94K | 0.01% | 542 |
|
|
2025
Q1 | $274K | Sell |
9,672
-2,000
| -17% | -$56.7K | 0.01% | 506 |
|
|
2024
Q4 | $485K | Sell |
11,672
-46,312
| -80% | -$1.93M | 0.01% | 357 |
|
|
2024
Q3 | $3.88M | Buy |
57,984
+900
| +2% | +$60.1K | 0.1% | 183 |
|
|
2024
Q2 | $6.78M | Sell |
57,084
-6,817
| -11% | -$810K | 0.18% | 119 |
|
|
2024
Q1 | $6.81M | Buy |
63,901
+2,479
| +4% | +$264K | 0.19% | 122 |
|
|
2023
Q4 | $6.11M | Hold |
61,422
| – | – | 0.19% | 123 |
|
|
2023
Q3 | $6.34M | Buy |
61,422
+10,760
| +21% | +$1.11M | 0.23% | 109 |
|
|
2023
Q2 | $6.16M | Buy |
50,662
+1,486
| +3% | +$181K | 0.22% | 103 |
|
|
2023
Q1 | $7.55M | Buy |
49,176
+18,872
| +62% | +$2.9M | 0.31% | 84 |
|
|
2022
Q4 | $5.44M | Sell |
30,304
-63,562
| -68% | -$11.4M | 0.57% | 37 |
|
|
2022
Q3 | $11.1M | Sell |
93,866
-280
| -0.3% | -$33.1K | 0.53% | 39 |
|
|
2022
Q2 | $13.4M | Sell |
94,146
-200
| -0.2% | -$28.6K | 0.6% | 31 |
|
|
2022
Q1 | $16.3M | Sell |
94,346
-200
| -0.2% | -$34.5K | 0.6% | 27 |
|
|
2021
Q4 | $24M | Buy |
94,546
+2,291
| +2% | +$582K | 0.85% | 18 |
|
|
2021
Q3 | $35.5M | Sell |
92,255
-13,246
| -13% | -$5.1M | 1.39% | 9 |
|
|
2021
Q2 | $24.8M | Buy |
105,501
+588
| +0.6% | +$138K | 0.94% | 17 |
|
|
2021
Q1 | $13.7M | Buy |
104,913
+3,571
| +4% | +$468K | 0.48% | 42 |
|
|
2020
Q4 | $10.6M | Sell |
101,342
-100
| -0.1% | -$10.4K | 0.48% | 37 |
|
|
2020
Q3 | $7.18M | Buy |
101,442
+34,342
| +51% | +$2.43M | 0.3% | 69 |
|
|
2020
Q2 | $4.31M | Buy |
67,100
+1,100
| +2% | +$70.6K | 0.24% | 81 |
|
|
2020
Q1 | $1.98M | Buy |
66,000
+35,000
| +113% | +$1.05M | 0.14% | 127 |
|
|
2019
Q4 | $606K | Buy |
+31,000
| New | +$606K | 0.03% | 304 |
|